FinESS Registry Study

NCT00849953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2011-06-28

No results posted yet for this study

Summary

A prospective, post-approval registry study assessing subject rhinosinusitis symptomatic status over time following treatment with FinESS Sinus Treatment using self-administered quality of life survey data.

Conditions

  • Rhinosinusitis

Sponsors & Collaborators

  • Entellus Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Jeff Grebner · Entellus Medical

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00849953 on ClinicalTrials.gov